US equities |
INTC $65.51 ▼-28.85% AMZN $236.21 ▼-3.11% MU $886.41 ▼-5.12% NVDA $206.02 ▼-3.58% SNDK $1,186.54 ▼-10.79% GOOGL $279.95 ▼-1.36% AMD $510.41 ▼-9.89% TSLA $396.75 ▼-1.62%
FinancialContent

Immuron Limited - American Depositary Shares (NQ:IMRN)

0.8999 -0.0201 (-2.18%)
Delayed Quote Updated: 9:32 AM EDT, Oct 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Immuron Limited - American Depositary Shares

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Immuron continued quarterly sales growth
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron CEO, Steven Lydeamore presentation at Emerging Growth Conference
From Immuron Limited
Via GlobeNewswire
News headline image
Travelan® Phase 2 Study Results Published
From Immuron Limited
Via GlobeNewswire
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Gainers Immuron (NASDAQ:IMRN) shares moved upwards by 48.2% to $1.65 during Friday's regular session. The market value of their outstanding shares is at $8.9 million. bioAffinity Technologies... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Gainers Immuron (NASDAQ:IMRN) stock increased by 64.9% to $1.83 during Friday's pre-market session. The company's market cap stands at $8.9 million. Akanda (NASDAQ:AKAN) shares increased by 27.52% to... 
Via Benzinga
News headline image
Immuron to launch PROIBS® in the United States
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron Reports FY26 Preliminary Results
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron CEO, Steven Lydeamore presentation at Kalkine Media Webinar
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron FY26 Sales - Four Consecutive Quarters of Growth over Prior Year
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron Advances IMM-529 (Clostridioides difficile infection) Partnering Strategy
From Immuron Limited
Via GlobeNewswire
Which stocks have an unusual volume on Thursday? ↗
Via Chartmill
Wondering what's happening in today's after-hours session? ↗
Via Chartmill
News headline image
Emerging Growth Research Releases Flash Report on Immuron; Maintains Buy-Extended Rating and Raises Price Target to $4.00
Via ACCESS Newswire
News headline image
Immuron Double Digit 3Q Sales Growth
From Immuron Limited
Via GlobeNewswire
News headline image
Emerging Growth Research Issues Flash Update on Immuron Limited, Maintains Buy-Extended Rating and $3.90 Price Target
Via ACCESS Newswire
News headline image
Immuron CEO, Steven Lydeamore presentation at Coffee Microcaps Conference
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron Reports HY26 Results and Strategic Reset
From Immuron Limited
Via GlobeNewswire
News headline image
Emerging Growth Research Issues Flash Update on Immuron Limited, Maintains Buy-Extended Rating and $3.50 Price Target
Via ACCESS Newswire
News headline image
Immuron Reports Continued Sales Growth
From Immuron Limited
Via GlobeNewswire
News headline image
Keep an eye on the top gainers and losers in Wednesday's session. ↗
Wondering how the US markets performed in the middle of the day on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
News headline image
These stocks that are showing activity before the opening bell on Wednesday. ↗
Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics. 
Via Chartmill
News headline image
Immuron Limited (IMRN) Plunges Amidst Management Uncertainty and Bearish Market Sentiment
Immuron Limited (NASDAQ: IMRN) experienced a significant downturn in its stock performance today, December 3, 2025, with shares plummeting by a notable -12.05 percent. This sharp decline is largely... 
Via MarketMinute
News headline image
Immuron New U.S. Department of Defense Award & Clinical Trial Update
From Immuron Limited
Via GlobeNewswire
News headline image
Wondering what's happening in today's pre-market session? ↗
Let's have a look at what is happening on the US markets before the opening bell on Monday. Below you can find the top gainers and losers in today's pre-market session. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Immuron IMM-529 IND approved by FDA
From Immuron Limited
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Immuron Announces Clinical Trial Update
From Immuron Limited
Via GlobeNewswire
News headline image
Emerging Growth Research Initiates Coverage on Immuron Limited with a Buy-Extended Rating and $4.00 Price Target
New York, New York--(Newsfile Corp. - October 17, 2025) - Emerging Growth Research today announced the initiation of coverage on... 
Via Newsfile
< Previous 1 2 3 4 5 6 7 Next >